Chemical engineering meets cancer immunotherapy
Sachin Bhagchandani wins NCI Predoctoral to Postdoctoral Fellow Transition (F99/K00) Award.
Accelerating the pace of engineered cell therapies, from lab to bedside
Kytopen is speeding up both discovery and delivery of engineered cell therapies with its transformative Flowfect platforms.
Understanding antibodies to avoid pandemics
Structural biologist Pamela Björkman shared insights into pandemic viruses as part of the Department of Biology’s IAP seminar series.
Multimillion-dollar grant to MIT funds research into acute and chronic Lyme disease
Family’s health trauma translates into mission to solve a chronic health problem suffered by more than a million Americans.
Neural vulnerability in Huntington’s disease tied to release of mitochondrial RNA
Unique survey of gene expression by cell type in humans and mice reveals several deficits affecting the most vulnerable neurons.
Research highlights immune molecule’s complex role in Huntington’s disease
Knocking out the immune cytokine IL-6 exacerbates symptoms in HD model mice, affects neural connection genes.
Counting your antigens
A new platform that precisely quantifies antigens presented on cell surfaces may help researchers and clinicians improve the effectiveness of cancer immunotherapies.
Technique identifies T cells primed for certain allergies or infections
Researchers develop a method to isolate and sequence the RNA of T cells that react to a specific target.
Soft robotics breakthrough manages immune response for implanted devices
Discovery could enable longer-lasting and better-functioning devices — including pacemakers, breast implants, biosensors, and drug delivery devices.
Unmasking mutant cancer cells
A new dosing regimen for an old cancer drug shows new promise as an immunotherapy.
New vaccine strategy boosts T-cell therapy
Super-charging a treatment for leukemia also makes it effective on solid tumors.
A new approach to targeting tumors and tracking their spread
Researchers develop nanosized antibodies that home in on the meshwork of proteins surrounding cancer cells.
“Inactive” ingredients may not be, study finds
Most pills contain compounds with potential to cause allergic reactions or discomfort in some patients.
Committed to service and science
When senior Julia Ginder isn’t investigating the mystery of her own allergies, she’s volunteering to help young people reach their goals.
Study suggests glaucoma may be an autoimmune disease
Unexpected findings show that the body’s own immune system destroys retinal cells.